Compare Income Statements and Balance Sheets of Competitors a. Following are selected income statements from two pharmaceutical companies, Pfizer and Dr. Reddy's, for their respective 2018 fiscal years. Express each income statement amount as a percentage of sales. Note: Round percentage to one decimal point (for example, round 18.566% to 18.6%). Income Statement ($ millions) Pfizer Dr. Reddy's Sales 100% $1,897 100% Cost of goods sold $46,673 11,248 35,425 0% 1.009 0% Gross profic 0% 888 0% Total expenses 27,154 0% 888 0% Net income $8,271 0% $- 0% b. Following are selected balance sheets from two pharmaceutical companies, Pfizer and Dr. Reddy's, for their respective 2018 fiscal years. Express each balance sheet amount as a percentage of total assets. Note: Round percentage to one decimal point (for example, round 18.566% to 18.6%). Balance Sheet ($ millions) Pfizer Dr. Reddy's 0% $1,465 0% Current assets Long-term assets Total assets $43,436 109,496 $152,932 0% 1,781 0% 0% $3,246 0% 0% $931 0% Current liabilities Long-term liabilities Total liabilities. $27,716 55,511 204 394 0% 0% 1,325 0% Stockholders' equity 83,228 69,704 $152,932 0% 1,921 Total liabilities and equity. 0% $3,246 0%